SLA/LP humAb IgG
Critical components in assay development are standards or positive controls. As an alternative to characterized disease state plasma, DIARECT provides a human chimeric SLA/LP IgG antibody ideally paired with our SLA/LP antigen.
Critical components in assay development are standards or positive controls. As an alternative to characterized disease state plasma, DIARECT provides a human chimeric SLA/LP IgG antibody ideally paired with our SLA/LP antigen.